Search

Search results

768 results found

A neutralizing APOA5 monoclonal antibody reduces amounts of lipoprotein lipase in capillaries and triggers hypertriglyceridemia.

Yang, Ye, Anne P Beigneux, Troy L Lowe, Yan Q Chen, Katherine Xie, Hyesoo Jung, Yiping Tu, et al. 2026. “A Neutralizing APOA5 Monoclonal Antibody Reduces Amounts of Lipoprotein Lipase in Capillaries and Triggers Hypertriglyceridemia.”. Proceedings of the National Academy of Sciences of the United States of America 123 (1): e2528664123.

Response to Letter to the Editor Regarding "The relationship between treatment-related changes in total hip BMD measured after 12, 18, and 24 mo and fracture risk reduction in osteoporosis clinical trials: the FNIH-ASBMR-SABER project".

Vilaca, Tatiane, Marian Schini, Li-Yung Lui, Susan K Ewing, Austin R Thompson, Eric Vittinghoff, Douglas C Bauer, Richard Eastell, Dennis M Black, and Mary L Bouxsein. 2026. “Response to Letter to the Editor Regarding ‘The Relationship Between Treatment-Related Changes in Total Hip BMD Measured After 12, 18, and 24 Mo and Fracture Risk Reduction in Osteoporosis Clinical Trials: The FNIH-ASBMR-SABER Project’.”. Journal of Bone and Mineral Research : The Official Journal of the American Society for Bone and Mineral Research.

Patient experience with endoscopic ultrasound and magnetic resonance cholangiopancreatography for pancreatic cancer screening (The PATRIOT study).

Merino, Andy Silva-Santisteban, Kevin Enrique Ariza Manzano, Sarah Ballou, Abraham Fourie Bezuidenhout, Katharine A Germansky, and Mandeep S Sawhney. 2026. “Patient Experience With Endoscopic Ultrasound and Magnetic Resonance Cholangiopancreatography for Pancreatic Cancer Screening (The PATRIOT Study).”. Pancreatology : Official Journal of the International Association of Pancreatology (IAP) . [et Al.] 26 (2): 259-64.